Skip to content
Screener

Kodiak Sciences Inc KOD Other Income (Expense)

Other Income (Expense) at other companies

Regeneron Pharmaceuticals logo
Regeneron PharmaceuticalsREGN
$234.3M-46.7%
EyePoint, Inc. logo
EyePoint, Inc.EYPT
$2.91M+0.6%
KLR
Kalaris TherapeuticsKLRS
$977K+518%
4D Molecular Therapeutics logo
4D Molecular TherapeuticsFDMT
$4.86M-14.0%
PVL
Palvella TherapeuticsPVLA
-$32K-114%
BioCryst Pharmaceuticals logo
BioCryst PharmaceuticalsBCRX
-$18.99M+18.5%

Other financials

Income statement

See full
Operating income-$59.8M-1.2%
Net income-$58.2M-1.2%
EPS (diluted)-$0.94+13.8%

Balance sheet

See full
Cash & equivalents$169.5M+22.1%
Total debt$56.0M-17.2%
Total equity$112.1M+3.0%
Total assets$306.0M+2.7%

Cash flow

See full
Operating cash flow-$40.0M-37.6%
CapEx$942.0K+249%
Free cash flow-$41.0M-39.5%

Valuation

See full
Market cap$2.84B+556%
Enterprise value$2.73B+592%

Returns & leverage

See full
Return on equity-208.8%+2,306pp
Debt / equity0.5×-0.1×
Current ratio3.5×-1.1×

Where this comes from

Reported directly by Kodiak Sciences Inc in its filing.

Tagged under the XBRL concept us-gaap:OtherNonoperatingIncomeExpense.

The source filing: Kodiak Sciences Inc’s 10-Q, filed May 7, 2026.

Filed
May 7, 2026, 4:15 PM EDT
Fiscal quarter
Q1 FY2026
Calendar quarter
Q1 2026
Accession
0001193125-26-211951
Line itemThree Months Ended March 31, 2026Three Months Ended March 31, 2025
General and administrative11,23015,429
Total operating expenses59,77759,073
Loss from operations(59,777)(59,073)
Interest income1,6411,602
Other income (expense), net(22)10
Net loss and comprehensive loss$(58,158)$(57,461)
Net loss per share, basic and diluted$(0.94)$(1.09)
Weighted-average shares outstanding, basic and diluted61,859,48552,746,318

Item 1. Financial Statements (Unaudited).

FAQ

What is Kodiak Sciences Inc's other income (expense)?
Kodiak Sciences Inc (KOD) reported other income (expense) of -$22K in Q1 2026.
How has Kodiak Sciences Inc's other income (expense) changed year-over-year?
Kodiak Sciences Inc's other income (expense) decreased by 320.0% year-over-year, from $10K to -$22K.
What is the long-term trend for Kodiak Sciences Inc's other income (expense)?
Over 3 years (2021 to 2025), Kodiak Sciences Inc's other income (expense) has grown at a -20.4% compound annual growth rate (CAGR), from -$190K to -$96K.
What does other income (expense) mean?
Net total of all non-operating income and expenses not classified in specific line items — a catch-all for miscellaneous financial items.

Ask your AI about Kodiak Sciences Inc's other income (expense).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude